首页> 外文期刊>Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists >Treatment of ovarian anaplastic ependymoma by an aromatase inhibitor
【24h】

Treatment of ovarian anaplastic ependymoma by an aromatase inhibitor

机译:芳香化酶抑制剂治疗卵巢间变性室管膜瘤

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND:: Histopathologic diagnosis and treatment of ovarian anaplastic ependymoma are challenging. CASE:: A 61-year-old-woman presented with a 10-cm right adnexal tumor associated with peritoneal carcinomatosis extending to the right diaphragm and liver surface. After initial diagnosis of a papillary serous carcinoma, we performed extensive but nonoptimal cytoreductive surgery including hysterectomy with bilateral oophorectomy. Histology revealed some axially arranged cells with a prominent fibrillary cytoplasm, suggesting an ependymoma. Diagnosis was confirmed by immunophenotype showing strong positivity to glial fibrillary acidic protein. Given the strong tumoral expression of estrogen and progesterone receptors, an aromatase inhibitor was initiated. One year later, computed tomography scan showed stability of the residual peritoneal nodules. CONCLUSION:: Aromatase inhibitor treatment could be effective in cases of extraaxial ependymoma with prominent estrogen receptor expression.
机译:背景:卵巢间变性室管膜瘤的组织病理学诊断和治疗具有挑战性。病例:一位61岁的女性患者出现了一个10厘米长的右附件肿瘤,伴有腹膜癌,延伸至右right肌和肝表面。初步诊断为乳头状浆液性癌后​​,我们进行了广泛但非最佳的细胞减少手术,包括子宫切除术和双侧卵巢切除术。组织学显示一些轴向排列的细胞具有突出的纤维状细胞质,提示室管膜瘤。免疫表型对神经胶质原纤维酸性蛋白显示强阳性,从而确诊。鉴于雌激素和孕激素受体在肿瘤中的强烈表达,人们开始使用芳香化酶抑制剂。一年后,计算机断层扫描显示残余腹膜结节稳定。结论:芳香化酶抑制剂治疗在雌激素受体表达明显的轴外室间隔瘤中可能是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号